Chong Kun Dang will conduct joint marketing with Allergan Korea on eye disease treatments

Published: 2015-02-23 10:04:05

Updated: 2015-02-23 10:05:19

Chong Kun Dang (CEO Jung-woo Kim)had an agreement ceremony at Grand Hyatt Seoul on the 13^thfor joint marketing with Allergan Korea over two types of eye drops for ophthalmologic diseases.

Through the agreement, Chong Kun Dang will conduct co-marketing and sales of the Allergan’s xerophthalmia treatment ‘Restasis’ and anti-allergy medicine‘Relestat’ from this March.

Restasis Eye Drop is the wo...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.

Chong Kun Dang will conduct joint marketing with Allergan Korea on eye disease treatments

Chong Kun Dang (CEO Jung-woo Kim)had an agreement ceremony at Grand Hyatt Seoul on the 13thfor joint marketing with Allergan Korea over two types of eye drops for ophthalmologic diseases.

Fees

Chong Kun Dang (CEO Jung-woo Kim)had an agreement ceremony at Grand Hyatt Seoul on the 13^thfor joint marketing with Allergan Korea over two types of eye drops for ophthalmologic diseases.